Beta Bionics, Inc. (BBNX) PT Raised to $37 at Truist Securities
Tweet
Share
E-mailGet Alerts BBNX Hot Sheet
Price: $17.62 +7.44%
Rating Summary:
8 Buy, 3 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 17 | Down: 23 | New: 12
Rating Summary:
8 Buy, 3 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 17 | Down: 23 | New: 12
Join SI Premium – FREE
Truist Securities analyst Richard Newitter raised the price target on Beta Bionics, Inc. (NASDAQ: BBNX) to $37.00 (from $32.00) while maintaining a Buy rating.
You May Also Be Interested In
- Bicara Therapeutics Inc (BCAX) PT Raised to $39 at BTIG
- Trex (TREX) PT Raised to $49 at Stifel
- Freedom Broker Upgrades Alico Inc. (ALCO) to Buy
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
